Fan X, Guo D, Cheung A, Poon Z, Yap C, Goh S, et al. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018;24:1971-1980 pubmed publisher

Vaccari M, Fourati S, Gordon S, Brown D, Bissa M, Schifanella L, et al. HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition. Nat Med. 2018;24:847-856 pubmed publisher

Denzin L, Khan A, Virdis F, Wilks J, Kane M, Beilinson H, et al. Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. Immunity. 2017;47:310-322.e7 pubmed publisher

Hoppstädter J, Seif M, Dembek A, Cavelius C, Huwer H, Kraegeloh A, et al. M2 polarization enhances silica nanoparticle uptake by macrophages. Front Pharmacol. 2015;6:55 pubmed publisher

van Lith M, McEwen Smith R, Benham A. HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. J Biol Chem. 2010;285:40800-8 pubmed publisher

Jones E, Fugger L, Strominger J, Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol. 2006;6:271-82 pubmed

Nishimura Y, Oiso M, Fujisao S, Kanai T, Kira J, Chen Y, et al. Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases. Int Rev Immunol. 1998;17:229-62 pubmed